NCT00203931View on ClinicalTrials.gov

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2009

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Cetuximab

DRUG

Pemetrexed

Trial Locations (1)

60637

The University of Chicago, Chicago

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Chicago

OTHER

NCT00203931 - Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter